PAR
Click for more information
0.00% 29.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-24

  1. Gan_Gans
    2,124 Posts.
    lightbulb Created with Sketch. 568
    clock Created with Sketch.
    04/10/22
    09:54
    Post #: 64011551
    No we don’t.

    if you’d like to go for a run on this and report back to us - that’d be awesome.

    PAR Price at posting: $1.26 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
DMP Domino's locks in biggest faller status on Thursday as it closes stores in Asia, Europe
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $103.1M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 62363 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 78600 3
View Market Depth
Last trade - 10.05am 22/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.